Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study.
about
Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money.Real-life Efficacy of Omalizumab After 9 Years of Follow-up.Severe asthma and quality of lifeBiologic agents for severe asthma patients: clinical perspectives and implications.An update on the management of aspirin-exacerbated respiratory disease.Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea.
P2860
Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Omalizumab Improves Quality of ...... A Randomized Phase III Study.
@en
type
label
Omalizumab Improves Quality of ...... A Randomized Phase III Study.
@en
prefLabel
Omalizumab Improves Quality of ...... A Randomized Phase III Study.
@en
P2093
P2860
P1476
Omalizumab Improves Quality of ...... A Randomized Phase III Study.
@en
P2093
Changzheng Wang
China Omalizumab Study Group
Ioannis Kottakis
Linda Wang
Michael Humphries
P2860
P304
P356
10.4168/AAIR.2016.8.4.319
P577
2016-07-01T00:00:00Z